North America Diagnostic Catheter Market

North America Diagnostic Catheter Market Size (2022 to 2027)

The size of the Diagnostic Catheter Market in North America is valued at USD 1.95 billion in 2022. It is estimated to be growing at a CAGR of 7.2% to reach USD 2.76 billion by 2027.

An increasing number of minimally invasive surgeries and diagnostic imaging centers and the technological advancements in the imaging catheter area are together, hiking the growth of the diagnostic catheter market in North America.

The growing incidence of cardiac diseases in the United States is expected to boost the North America Diagnostic Catheter Market significantly. According to a December 2016’s study conducted by the researchers at the National Institute of Health, 2,25 cases were identified for every 1000 people in the United States as supraventricular tachycardia, which is cardiac disease.

On the other end, the cases of atrial fibrillation are also on the rise in the United States. As per the statistics published by the Centre for Disease Control and Prevention, around 2.7 to 6.1 million people were diagnosed with atrial fibrillation. This factor is estimated to drive an additional boost to the market growth in North America.

The high cost of the diagnostic catheters is expected to restrain the market growth to a small extent. The absence of the skilled professional and recycling processes of single-use diagnostic catheters are majorly challenging the market.

This research report on North America Diagnostic Catheter Market has been segmented and sub-segmented into the following categories:

• By Type: Imaging catheters and Non-imaging catheters.                   
• By Application: Neurology, Urology, Gastroenterology, Cardiology, and Others (Bronchoscopy and Gynaecology)
• By End-User: Hospitals, Imaging and Diagnostic Centres
• By Country: The United States, Canada & Rest of North America

Geographically, North America is leading the global market with U.S.A being the regional dominator. The United States has a well-developed infrastructure, and high investments for the R&D towards the diagnostic catheters are likely to surge the growth for the market.

On the other end, the Canadian market is estimated to showcase a prominent CAGR during the forecast period. The launch of new catheter technologies in design, growing investments made by the government, and other private organizations, rising investments are expected to drive the market growth in Canada.

Promising Companies leading the North America Diagnostic Catheter Market Profiled in the Report are Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic plc (Ireland), Johnson & Johnson (U.S.), Koninklijke Philips N.V. (Netherlands), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Cardinal Health, Inc. (U.S.), Edward Lifesciences Corporation (U.S.), and Terumo Corporation (Japan).